1. Blair M. Diabetes Mellitus Review. Urol Nurs 2016;36(1):27-36. [
DOI:10.7257/1053-816X.2016.36.1.27] [
PMID]
2. Chikezie PC, Ojiako OA, Ogbuji AC. Oxidative stress in diabetes mellitus. Int J Biol Chem 2015;9(3):92-109. [
DOI:10.3923/ijbc.2015.92.109]
3. Sen S, Chakraborty R, De B. Oxidative Stress and Diabetes Mellitus. Clin Chem Lab Med 2011;49(11):1773-82. [
Google Scholar]
4. Shetty S, Copeland PR. Molecular mechanism of selenoprotein P synthesis. Biochim Biophys Acta Gen Subj 2018;1862(11):2506-10. [
DOI:10.1016/j.bbagen.2018.04.011] [
PMID] [
PMCID]
5. Burk RF, Hill KE. Selenoprotein P expression, functions, and roles in mammals. Biochim Biophys Acta 2009;1790(11):1441-7. [
DOI:10.1016/j.bbagen.2009.03.026] [
PMID] [
PMCID]
6. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 2010;12(5):483-95. [
DOI:10.1016/j.cmet.2010.09.015] [
PMID]
7. Takayama H, Misu H, Iwama H, Chikamoto K, Saito Y, Murao K, et al. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. J Biol Chem 2014;289(1):335-45. [
DOI:10.1074/jbc.M113.479386] [
PMID] [
PMCID]
8. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011;96(8):E1325-9.. [
DOI:10.1210/jc.2011-0620] [
PMID]
9. Ranjbar A, Khani-Jazani R, Sedighi A, Jalali-Mashayekhi F, Ghazi-Khansari M, Abdollahi M. Alteration of body total antioxidant capacity and thiol molecules in human chronic exposure to aluminum. Toxicol Environ Chem 2008;90(4):707-13. [
DOI:10.1080/02772240701660650]
10. Ranjbar A, Pasalar P, Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Hum Exp Toxicol 2002;21(4):179-82. [
DOI:10.1191/0960327102ht238oa] [
PMID]
11. Wang X, X Hai C. ROS acts as a double-edged sword in the pathogenesis of type 2 diabetes mellitus: is Nrf2 a potential target for the treatment? Mini Rev Med Chem 2011;11(12):1082-92. [
DOI:10.2174/138955711797247761] [
PMID]
12. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6(3):456. [
DOI:10.4239/wjd.v6.i3.456] [
PMID] [
PMCID]
13. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62. [
DOI:10.2337/dc10-S062] [
PMID] [
PMCID]
14. Ali SA, Nassif WMH, Abdelaziz DHA. Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: a case-control study. Clin Res Hepatol Gastroenterol 2016;40(4):465-70. [
DOI:10.1016/j.clinre.2015.12.003] [
PMID]
15. Takayama H, Misu H, Iwama H, Chikamoto K, Saito Y, Murao K, et al. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. J Biol Chem 2014;289(1):335-45. [
DOI:10.1074/jbc.M113.479386] [
PMID] [
PMCID]
16. Maritim AC, Sanders A, Watkins Iii JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol 2003;17(1):24-38. [
DOI:10.1002/jbt.10058] [
PMID]
17. Du X-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000;97(22):12222-6. [
DOI:10.1073/pnas.97.22.12222] [
PMID] [
PMCID]
18. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17(3):171-80. [
DOI:10.1046/j.1464-5491.2000.00259.x] [
PMID]
19. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002;51(10):2951-8. [
DOI:10.2337/diabetes.51.10.2951] [
PMID]
20. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17(3):171-80. [
DOI:10.1046/j.1464-5491.2000.00259.x] [
PMID]
21. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979;21(1):104-7. [
DOI:10.1016/0006-2944(79)90061-9]